
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Aldehyde dehydrogenase 1-A2/ALDH1A2 CRISPR/Cas9 KO Plasmid (m) | sc-422592 | 20 µg | $397.00 | |||
Aldehyde dehydrogenase 1-A2/ALDH1A2 HDR Plasmid (m) | sc-422592-HDR | 20 µg | $445.00 |
Mouse Aldh1a2 encodes aldehyde dehydrogenase 1-A2 (ALDH1A2), a retinaldehyde dehydrogenase that catalyzes the oxidation of retinaldehyde to retinoic acid, a key morphogen controlling gene expression programs during development. ALDH1A2-driven retinoic acid synthesis regulates nuclear receptor signaling (RAR/RXR) and influences pathways governing cell differentiation, tissue patterning, and organogenesis, including limb and axial development. Perturbation of Aldh1a2 function is widely used to model disrupted retinoid metabolism and transcriptional regulation, with relevance to congenital malformations and developmental phenotypes. As retinoic acid gradients also shape immune and epithelial homeostasis, Aldh1a2 loss-of-function models support mechanistic studies of context-dependent retinoid signaling in mouse systems.
Aldehyde dehydrogenase 1-A2/ALDH1A2 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Aldh1a2 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Aldh1a2 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, Aldehyde dehydrogenase 1-A2/ALDH1A2 HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Aldh1a2 target site.
When co-transfected with Aldehyde dehydrogenase 1-A2/ALDH1A2 CRISPR/Cas9 KO Plasmid (m):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Aldh1a2 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.